Data from various clinical studies and meta-analyses confirmed the applicability of the infection-mediated clinical biomarkers IL-6, VEGF-D, SAA, CRP, serum ferritin, and PCT as prognostic and adjunct diagnostic indicators for developing electrical-based COVID-19 biosensors. This evidence concerns the gene CALCA and COVID-19.